AngioDynamics, Inc. vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ANGO | RMD | |
|---|---|---|
| Market Cap | $635.28 million | $32.93 billion |
| Revenue (TTM) | $320.17 million | $5.65 billion |
| Net Income (TTM) | $-36,742,000 | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| ANGO | RMD | |
|---|---|---|
| P/E Ratio | — | 21.90 |
| Price / Book | 3.72 | 5.00 |
| Price / Sales | 1.98 | 5.82 |
ANGO leads on 2 of 2 valuation factors.
Profitability
| ANGO | RMD | |
|---|---|---|
| Net Margin | -11.48% | 26.94% |
| Return on Equity | -21.51% | 23.13% |
RMD leads on 2 of 2 profitability factors.
Dividend
| ANGO | RMD | |
|---|---|---|
| Dividend Yield | — | 1.16% |
| Payout Ratio | — | 25.31 |
ANGO and RMD split the dividend factors evenly.
Risk & Sentiment
| ANGO | RMD | |
|---|---|---|
| Short Interest | 4.46% | 4.04% |
RMD leads on 1 of 1 risk & sentiment factors.
Dig deeper: ANGO overview, ANGO financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.